Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-24

Clinical Trial Update: Tensi+ for Treating Overactive Bladder: A Randomized Controlled Trial [NA]

View source ↗

Summary

A randomized controlled trial evaluating Tensi+ for overactive bladder is listed, sponsored by Stimuli Technology, but the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tensi+

Snippet

Sponsor: Stimuli Technology | Conditions: Overactive Bladder (OAB) | NA | Status: NOT_YET_RECRUITING